Longevity Clinics in France

In France, almost all longevity testing is paid for out of pocket, because an examination ordered for someone with no symptoms generally sits outside the nomenclature of acts that Assurance Maladie, the statutory health insurance scheme, will reimburse. That puts the private market alongside one of Europe's more comprehensive public systems rather than inside it. The same person can be reimbursed for a scan a doctor had a clinical reason to order, and pay the full price for the identical scan when the reason was curiosity.

The operators fall into a few recognisable shapes. Private check-up centres, usually attached to a clinique - the French term for a private hospital - sell a half-day bilan de sante, or health check-up, built around blood work, imaging and a cardiology review, while radiology groups sell scans directly to people paying for themselves and doctor-led practices in endocrinology, sports medicine, nutrition or aesthetic medicine have bolted extended blood panels, hormone consultations and infusions onto a consultation business they already had. Residential programmes cluster in the thermal spa towns and the coastal thalassotherapy resorts, where treatment is built around heated sea water and a medicalised week has been grafted onto a spa industry far older than longevity marketing, and at the thin end sit single-service operators selling one thing - an intravenous drip, a cryotherapy cabin - sometimes from premises that are not a medical practice at all.

Assurance Maladie covers a share of the cost of care for everyone insured in France, and a complementaire sante - a top-up policy from a mutuelle or a commercial insurer - normally pays the rest. For a person who feels well, prevention inside that system is deliberately narrow and mostly free: organised screening invites women aged 50 to 74 for a mammogram every two years, women and men aged 50 to 74 for a home bowel test every two years, and women aged 25 to 65 for cervical screening. Two further offers exist for people with no complaint at all - Mon bilan prevention, a covered prevention consultation at four life stages between 18 and 75, and the examen de prevention en sante, a free check of about two hours at roughly a hundred health examination centres run by Assurance Maladie.

What the system does not do is test well people broadly, and that is a considered position rather than a gap in provision. The Haute Autorite de Sante, the national body that appraises medical practice, concluded in 2013 that a screening programme using the total prostate specific antigen (PSA) blood test is not recommended, in the general population or in men at higher risk - false alarms, the biopsies that follow them and the treatment of cancers that would never have surfaced were not offset by a demonstrated gain. The same reasoning explains the absence of any public programme of whole-body imaging, wide metabolic panels or biological age testing: the case that measuring more in a person without symptoms lengthens their life has not been made.

Much of what these clinics sell has an ordinary route when there is a clinical reason for it. A medecin traitant - the registered general practitioner who coordinates your care - can order blood work at a laboratoire de biologie medicale, a licensed medical testing laboratory, and refer you for imaging, cardiology, endocrinology or sleep testing, all reimbursed, and a secteur 1 general practice consultation, billed at the agreed tariff with no supplement, has cost 30 euros since 22 December 2024. Nor is the equipment available simply on request: article R.1333-46 of the Code de la sante publique requires a medical exposure to ionising radiation to carry enough benefit to the person to justify its risk, article R.6122-26 makes magnetic resonance imaging units, medical scanners and hyperbaric chambers heavy equipment that each need an authorisation from an agence regionale de sante, the regional health authority, and article R.4311-7 has a nurse give injections and infusions on a written, dated and signed medical prescription.

Longevity medicine is not a speciality in France. The recognised specialities are the diplomes d'etudes specialisees, the specialist medical qualifications listed in the ministerial order of 21 April 2017, and neither longevity medicine nor medecine anti-age appears among them, so anyone offering it is registered under some other qualification: every doctor lawfully practising here appears on the tableau of the Ordre des medecins, the statutory register, whose national council runs a public online search showing the qualifications each doctor holds, and Assurance Maladie's own annuaire sante directory separately shows which fee sector a practitioner works in. French doctors also work under a code of conduct that still states medicine is not to be practised as a trade, and which since December 2020 lets them publish information about their practice while forbidding testimonials from third parties, comparison with other doctors or establishments and any encouragement to undergo unnecessary preventive or care acts.

Several of the products sold under this heading run into specific French rules. A medicine cannot be sold or given away without a marketing authorisation from the Agence nationale de securite du medicament et des produits de sante, the French medicines regulator, or from the European Union, which is the wall most unlicensed injectables hit; initial prescription of testosterone medicines is reserved to specialists in endocrinology and diabetology, urology, gynaecology, and reproductive medicine and andrology, though any doctor may renew it; growth hormone carries an annual hospital initial prescription reserved to paediatric and endocrinology specialists, and is reimbursed for a defined list of growth disorders rather than for ageing; and cell therapy preparations need that regulator's authorisation, with hospital-exemption cell medicines prepared for one named patient and used in a hospital. Genetic testing is tightest of all: article 16-10 of the Code civil permits examination of a person's constitutional genetic characteristics only for medical or scientific research purposes and bans advertising solicitation for it, and article 226-28-1 of the Code penal fines the person who requests such a test outside those conditions 3,750 euros.

A French mutuelle, the top-up insurer that covers what Assurance Maladie does not, will not normally pay for any of this. Complementary cover is built around what the statutory scheme already reimburses - the standard contrat responsable, the policy design most French top-up cover follows, is defined by its cover of the patient's share of the official tariffs for reimbursable care - so a service billed hors nomenclature or non remboursable, the two labels French practitioners use for anything outside the official lists, has no such tariff and falls outside both. Some policies carry a small annual prevention allowance, which is a budget the policyholder may spend, not cover for a screening programme.

Two quotes differ mostly on what sits inside them and on who reads the results. A price may or may not include the imaging, the laboratory work, a second appointment where a doctor explains what came back and a written report, and it also turns on whether the practitioner is secteur 1 and charges the agreed tariff, secteur 2 and free to charge above it, or outside the convention altogether, where Assurance Maladie reimburses a tarif d'autorite - a token fallback rate - of well under two euros for a specialist consultation. Under the ministerial order of 30 May 2018, a health professional must tell you in advance when a service is not reimbursable by the statutory scheme, and must put fee information in writing once the supplements on the acts billed reach 70 euros, so ask for an itemised written quote naming each act, marking which are hors nomenclature, and saying who follows up an abnormal result and at whose expense.

If you are travelling in for this, the thing to settle before booking is who owns the result after you leave. A finding that needs repeating or explaining goes back to a doctor at home, and a visitor has no medecin traitant in France to receive it, so ask whether the clinic writes to your own doctor, whether anything is filed to Mon espace sante - the state digital health record open to people insured in France - and whether an ambiguous result means a second trip. Reimbursement does not travel: planned care abroad is handled for French residents by the Centre national des soins a l'etranger, and only for care that would have been reimbursable in France, which a self-pay screening package is not.